Company Info
| Phone: | (206) 568-1466 |
| Year Established: | 2008 |
| Ticker: | IMPL |
| Exchange: | OTCQX |
Contacts
| Primary: | Len Paolillo Interim Presient & CEO |
| Other: | Leonard S. Paolillo CCO John Hoekman CTO & CDO Scott Youmans Senior VP, Technical Operations Lynn Gold Senior VP of Regulatory Michael Malafronte VP of Quality Assurance Michael W. Kalb CFO |
Company Description
Impel Pharmaceuticals is a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs.
